Clinical Trials Browser

INDUSTRY × Lymphoma, B-Cell × Immunotherapy, Adoptive × Clear all

NCT02965092 2019-05-10

CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma